药品注册申请号:207494
申请类型:ANDA (仿制药申请)
申请人:PRINSTON INC
申请人全名:PRINSTON PHARMACEUTICAL INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 150MG BASE No No AB 2016/11/15 2016/11/15 Prescription
002 DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE No No AB 2016/11/15 Prescription
003 DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 50MG BASE No No AB 2019/02/19 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2016/11/15 ORIG-1(原始申请) Approval STANDARD
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/09/18 SUPPL-9(补充) Approval Labeling-Package Insert STANDARD
2023/09/18 SUPPL-6(补充) Approval Labeling-Medication Guide,Labeling-Container/Carton Labels STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:DOXYCYCLINE HYCLATE; 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL; 规格:EQ 150MG BASE; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
200856 003 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 150MG BASE Prescription No No AB 2013/04/30 HERITAGE
207494 001 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 150MG BASE Prescription No No AB 2016/11/15 PRINSTON INC
213075 003 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 150MG BASE Prescription No No AB 2022/01/03 ALEMBIC
208741 007 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 150MG BASE Discontinued No No AB 2023/08/11 LUPIN
>>>活性成分:DOXYCYCLINE HYCLATE; 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL; 规格:EQ 200MG BASE; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050795 005 NDA DORYX DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Prescription Yes No AB 2013/04/11 MAYNE PHARMA
207494 002 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Prescription No No AB 2016/11/15 PRINSTON INC
090134 004 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Prescription No No AB 2018/05/22 ACTAVIS ELIZABETH
200856 004 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Prescription No Yes AB 2018/11/13 HERITAGE
213075 004 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Prescription No No AB 2022/01/03 ALEMBIC
208741 008 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 200MG BASE Discontinued No No AB 2023/08/11 LUPIN
>>>活性成分:DOXYCYCLINE HYCLATE; 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL; 规格:EQ 50MG BASE; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
090134 003 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 50MG BASE Prescription No No AB 2018/05/22 ACTAVIS ELIZABETH
207494 003 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 50MG BASE Prescription No No AB 2019/02/19 PRINSTON INC
208741 001 ANDA DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE TABLET, DELAYED RELEASE;ORAL EQ 50MG BASE Discontinued No No AB 2023/08/11 LUPIN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database